GPT and metabolic dysfunction-associated steatotic liver disease: In this study, after treatment with BSP-1, elevated levels of TC, TG, and liver transaminases (ALT, AST) were significantly reduced, indicating that BSP-1 can alleviate liver cell damage caused by MASLD and improve lipid metabolism.